Identifying Risk Factors of Bone Mass States Transition for Postmenopausal OsteoporosisIntegrating W

来源 :世界中医药大会第三届夏季峰会暨大健康博览会 | 被引量 : 0次 | 上传用户:watta515
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective:The aim is to screen out risk factors affecting bone mass states transition for postmenopausal osteoporosis(PMOP)based on western medicine risk factors and traditional Chinese medicine(TCM)symptoms.Methods:The questionnaire survey and bone mineral density tests were conducted lasting for 3 years from March 2009 to November 2011.Every subject was regularly contacted and interviewed annually.The characteristics of the population with different bone mass states transition were described.Risk factors were selected through univariate and multivariate analysis of Markov model.Likelihood ratio test was used to compare the fitting effect of different variables for the same data.Results:A total of 1021 participants were followed up for three consecutive years.In the period of follow up,80 women suffered the normal-osteopenia transition,43 women suffered the osteopenia-osteoporosis transition.Duration of menopause,height loss,and TCM symptoms including soreness and weakness of waist and knees,hair loss and leg pains were possible western medicine risk factors of transition states for PMOP(P<0.05).Fresh vegetables diet could reduce the risk of transition(P<0.05).The Markov model based on the western medicine risk factors and TCM symptoms had a satisfactory fitting degree.Conclusion:The importance of TCM symptoms should be paid attention to the screening and early warning of the population with high risk of PMOP.Markov model could be used for identifying risk factors of bone mass states transition for PMOP.
其他文献
目的:临床药师通过万古霉素血药浓度监测结果,参与制定个体化的给药方案的临床实践.方法:监测特殊群体患者万古霉素的血药浓度,根据监测结果以及患者的临床表现,设计个体化给药
目的:结合临床实践,探讨心血管内科药学服务.方法:通过案例分析,总结笔者在心血内科工作的经历与体会.结论:通过药品使用总体情况、基本药物使用情况、省医保扣款情况、医嘱点评
通过建立小鼠哮喘免疫耐受模型探讨特异性免疫治疗之机制.方法:选择BALB/c小鼠18只为研究对象,按随机数字表法分为3组:哮喘免疫耐受模型组(A组)、哮喘对照组(B组)、正常对照
目的:对1例使用多西他赛单周方案治疗晚期胃癌的患者进行分析,为该类患者的临床用药提供参考.方法:临床药师参与患者的整个药物治疗过程,结合患者的临床症状和用药情况提出药学
目的:探讨耐甲氧西林金黄色葡萄球菌(MRSA)的抗感染治疗方案.方法:临床药师通过对1例颅内MRSA感染的患者,重点制订个体化治疗方案及监护.在使用万古霉素出现肾损害时,为减轻肾
目的:为小儿患者感染马红球菌提供用药参考.方法:通过参与1例小儿感染马红球菌的药物治疗实践,协助医师为患者制订药物治疗方案,对该患儿提出合理的药学监护措施.结果:通过实施
目前慢病已经是最主要的死亡原因,对慢病进行健康管理可以减轻患者和家庭的各种负担,提高患者的生活质量,因此,科学而完善的慢病管理就显得尤为重要.本文结合我院临床药师参
目的:探讨应用PDCA循环管理在规范医院Ⅰ类切口围手术期预防使用抗菌药物的持续改进的应用及促进临床抗菌药物合理使用. 方法:由HIS系统导出Ⅰ类切口手术病历,对不合理现象
本文介绍了蜂疗的相关内容以及蜂疗在国内外的发展历史以及发展现状,具体的将蜂疗所涉及的范围,方式等内容作了详细的介绍.立足目前国内外蜂疗形式,对蜂疗的新发展提出发展方
目的:探讨蜂毒对不同类型肿瘤细胞的增殖抑制及诱导凋亡作用,并初步观察蜂毒抗肿瘤作用的细胞形态学改变. 方法:采用CCK-8法检测蜂毒对体外培养的多种肿瘤细胞株的增殖抑制